A 52 Week High for Biogen Idec, will it Hold?

biib New York, April 4th (TradersHuddle.com) - Shares of Biogen Idec Inc. (NASDAQ:BIIB) booked a new 52 week high today by trading above $128.87, traders are definitely monitoring Biogen's price action to see if this move attracts further buying into the stock.

Biogen Idec Inc. (NASDAQ:BIIB) develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The products from the biotechnology company addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis. The company was founded in 1985 and is based in

Biogen Idec is currently trading 0.36% versus its previous trading session close, and it has calculated support and resistance at $116.44 and $127.85 respectively. Clearly, with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range.

The overall market index S&P 500 is trading lower by -1.18% from its previous trading close, which means that Biogen Idec stock is outperforming the overall market.

TradersHuddle Search

Stock Search:


Site Search:

Loading

Technical Scans

Recent Trading Ideas

Latest Partner Headlines

Stock Market

Loading
Chart
o Dow Jones 17,387.21 ▼291.49 (-1.65%)
o S&P 500 2,029.55 ▼27.54 (-1.34%)
o NASDAQ 4,681.50 ▼90.27 (-1.89%)
INDEXDJX:.DJI

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:17,387.21 Trade time:4:31PM EST Value change:▼291.49 (-1.65%)
INDEXSP:.INX

S&P 500

Company ID [INDEXSP:.INX] Last trade:2,029.55 Trade time:4:31PM EST Value change:▼27.54 (-1.34%)
INDEXNASDAQ:.IXIC

NASDAQ

Company ID [INDEXNASDAQ:.IXIC] Last trade:4,681.50 Trade time:5:15PM EST Value change:▼90.27 (-1.89%)

In The Wires

Copyright © 2013 TradersHuddle.com. All Rights Reserved.